Die dritte Säule der organprotektiven Therapie
- PMID: 37081358
- DOI: 10.1007/s15006-023-2565-0
Die dritte Säule der organprotektiven Therapie
Comment on
-
Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis.Eur Heart J. 2022 Feb 10;43(6):474-484. doi: 10.1093/eurheartj/ehab777. Eur Heart J. 2022. PMID: 35023547 Free PMC article. Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources